COMMUNIQUÉS West-GlobeNewswire

Acquisition of Own Shares
08/09/2026
Mechelen, Belgium; 08 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
08/09/2026
Mechelen, Belgium; 8 September 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the Morgan Stanley 24th Annual Global Healthcare [...]
Celldex to Present at Upcoming Investor Conference
08/09/2026
HAMPTON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the upcoming Cantor Global Healthcare Conference on September 10, 2026 at 8: [...]
Keros Therapeutics Announces $5 Million Share Repurchase Authorization
08/09/2026
LEXINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
08/09/2026
Event to be webcast live on September 9, 2026 at 7:30 a.m. ET BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for [...]
Ascendis Pharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
08/09/2026
COPENHAGEN, Denmark, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare [...]
Inventiva to Present Multiple Abstracts at Paris MASH 2026
08/09/2026
Phase 1 and Phase 2 clinical data showed lanifibranor improves metabolic profile and cardiovascular risk factors in patients with MASH with or without type 2 diabetes Preclinical data further characterize lanifibranor’s [...]
Inventiva présentera plusieurs abstracts lors du Congrès Paris MASH 2026
08/09/2026
Des données d’études cliniques de Phase 1 et Phase 2 montrent que le lanifibranor améliore le profil métabolique et certains facteurs de risque cardiovasculaire chez les patients atteints de MASH, avec ou sans diabète [...]
Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer
08/09/2026
Experienced finance executive and former Big Four auditor to lead corporate finance strategy, and capital markets initiatives PARAMUS, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a [...]
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
08/09/2026
– Assembly Bio to share 40% of U.S. development costs and profits for helicase-primase inhibitor program for recurrent genital herpes – – Cash runway remains projected into 2029, including the first $75 million [...]
HealthEx Empowers Consumers to Bring Their Personal Health History to Muse, Meta’s New Personal AI Agent
08/09/2026
Americans can connect their health history to Muse using HealthEx and make progress on their health goals with a plan that adapts to their life as their clinical context changes SAN FRANCISCO, Sept. 08, 2026 (GLOBE [...]
Maxim Hair Restoration Expands Hair Transplant Services on Long Island With New Hamptons Office
08/09/2026
Leading Hair Restoration Company Enhances Accessibility and Convenience for Clients in the Hamptons New York City, NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Maxim Hair Restoration , a 15-location organization that [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
08/09/2026
Company Announcement COPENHAGEN, Denmark; September 8, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 28,011 shares as a consequence of the exercise of employee warrants. The increase is effected [...]
CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
08/09/2026
Second Rare Pediatric Disease (RPD) Designation for QRX003 FDA Previously Granted RPD Designation for QRX003 in Netherton Syndrome If a New Drug Application (NDA) for QRX003 Is Approved for Peeling Skin Syndrome, Quoin [...]
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
08/09/2026
MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) , a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, [...]
Raw Garden Launches Solventless Live Rosin All-In-One
08/09/2026
Purpose-Built Hardware Delivers Clean, Consistent Live Rosin Flavor Without Compromise SANTA BARBARA, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Raw Garden , the premier name in California’s clean cannabis market for [...]
BrewDog fait son entrée dans le monde du rugby sous couvert d’un partenariat conclu pour cinq ans avec les Leicester Tigers et colore le stade de Welford Road en punk
08/09/2026
ELLON, Écosse et LONDRES, 08 sept. 2026 (GLOBE NEWSWIRE) -- BrewDog , leader de la bière artisanale au Royaume-Uni et l’une des marques de bière artisanale les plus reconnues au monde, marque du groupe Tilray Brands, [...]
IBA – TRANSPARENCY NOTIFICATION
08/09/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, September 8, 2026 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]
IBA SA – NOTIFICATION TRANSPARENCE
08/09/2026
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 8 septembre 2026, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le [...]

Pages